Header cover image

South Korean Pharmaceuticals & Biotech Strong Balance Sheet Stocks

UPDATED May 15, 2022

U.S. Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

145 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
A052670Cheilbio₩2,385.00-0.4%-27.2%₩68.2bn/aPS4.1xn/an/a
A054670Daehan New Pharm₩11,950.00-6.3%-0.4%₩164.2bn/aPS10.7xn/an/a
A060590CTCBIO₩10,250.002.0%44.4%₩243.9bn/aPS1.7xn/a0%
A002620Jeil Pharma Holdings₩12,150.00-4.7%-50.1%₩184.2bn/aPS-53.6xn/a0.5%
A041910EstechPharma₩9,110.000.2%-27.1%₩106.9bn/aPS15.5xn/a1.1%
A067290JW Shinyak₩4,055.00-0.7%-15.2%₩184.7bn/aPS211xn/a0%
A323990Vaxcell-Bio Therapeutics₩46,000.007.7%-46.8%₩716.2bn/aPB23.3xn/an/a
A068270Celltrion₩141,000.00-14.5%-46.6%₩20.1t₩210,894.83PS34xE13.1%0.5%
A011040Kyung Dong Pharmaceutical₩10,100.001.0%-5.2%₩267.4bn/aPS21.7xn/a5.0%
A023910Daihan PharmaceuticalLtd₩29,000.003.9%-23.5%₩167.4b₩40,000.00PS7.7xn/a1.4%
A127120DNA Link₩3,995.00-10.6%-12.7%₩73.3bn/aPS2.8xn/an/a
A138610NIBEC₩21,450.005.4%-37.2%₩200.1bn/aPS15.7xn/an/a
A049960Cell Biotech₩15,700.00-2.2%-19.5%₩111.7bn/aPS10.7xn/a2.9%
A038290Macrogen₩26,750.002.5%-18.2%₩261.6bn/aPS237.9xn/a1.1%
A002630ORIENT BIO₩916.00-9.3%-45.2%₩108.7bn/aPS1.8xn/an/a
A003120Ilsung Pharmaceuticals₩84,000.002.1%-6.8%₩123.1bn/aPS3xn/a0.9%
A083790CrystalGenomics₩4,695.00-2.0%-43.2%₩311.5bn/aPS7.5xn/an/a
A950220NeoImmuneTech₩6,200.00-1.9%-48.5%₩604.3bn/aPB3.8xn/an/a
A950200Psomagen₩5,730.00-1.2%-59.8%₩107.9bn/aPS3.8xn/an/a
A140410Mezzion PharmaLtd₩18,850.002.4%-65.3%₩490.7bn/aPS18.9xn/an/a
A012790Sinil Pharmaceutical₩9,900.000%-32.2%₩105.9bn/aPS16.2xn/a1.0%
A006620DongKoo Bio&Pharma₩7,080.00-0.1%-23.3%₩193.9bn/aPS21.1xn/a1.4%
A214370Caregen₩96,100.00-8.0%47.2%₩967.8bn/aPS37.2xn/a1.7%
A217330Cytogen₩59,800.000.3%-7.1%₩352.9bn/aPS1018xn/an/a
Page 1 of 7